All years

25.11.2016 - Pluriomics User Meeting

The NMI is sending their expert on MEA technologies to Leiden: Udo Kraushaar has wide experience in this field and will point out the advantages as well as the challenges of the MEA technologies.


24.11.2016 - Wirtschaftsministerium fördert NMI im RegioWIN-Projekt

Stärkung der regionalen Industrie und Spitzenforschung durch Aufbau eines Nanoanalytikzentrums im Technologiepark Tübingen-Reutlingen


21.11.2016 - Data collection for CiPA Myocyte study finalized within one month

Only approximately one month after being leveled-up to MEA core-site for CiPA Myocyte study we were able to complete the cultivation, recording and analysis of hiPSC-derived cardiomyocytes from Axiogenesis and Cellular Dynamics on the Multiwell syste


13.10.2016 - Ein Antikörper-Set gegen alles - Transkript über die neu gegründete Signatope GmbH

Wenn alles so läuft, wie es sich Oliver Pötz und sein Team erhoffen, dann könnte die frisch gegründete Firma Signatope den Markt für Proteinbiomarkertests bald gehörig aufmischen.


17 October 2016 - IMI SAFE-T and C-Path PSTC Obtain Regulatory Support For New Liver Safety Biomarkers

FDA and EMA Letters of Support Pave the Way for Clinical Qualification The Innovative Medicines Initiative (IMI) SAFE-T (Safer and Faster Evidence Based Translation) Consortium and The Critical Path Institute (C-Path) announced today that the U.S.